scholarly journals Unusual Infections Complicating the Use of Steroids with Severe Alcoholic Hepatitis: Report of 2 Cases

1995 ◽  
Vol 9 (2) ◽  
pp. 81-84
Author(s):  
Vitor Arantes ◽  
Pina Michieletti ◽  
Ross Cameron ◽  
Jenny Heathcote ◽  
Morris Sherman

Corticosteroid therapy for acute alcoholic hepatitis has been demonstrated to enhance survival in patients who are encephalopathic, and who do not have renal failure or gastrointestinal bleeding. However, the complications of steroid therapy in such patients have been less well documented. The authors report two patients with alcoholic liver disease who developed life-threatening infections after steroid therapy was started. The first patient initially developed diabetes followed by Fournier's gangrene of the perineum, and a lung abscess following septic emboli. The second patient had established alcoholic cirrhosis rather than alcoholic hepatitis. She developed a necrotic ulcer on the arm at the site of an intravenous line, which was infected with a rhizopus species. Despite surgical debridement the lesion progressed and contributed to her death. Treatment of alcoholic hepatitis with steroids is not innocuous, and physicians should be aware of the potential for life-threatening complications.

2019 ◽  
Vol 70 (1) ◽  
pp. e281
Author(s):  
Petra Fischer ◽  
Andreea Fodor ◽  
Adelina Horhat ◽  
Daniela Matei ◽  
Maria Imbuzan ◽  
...  

QJM ◽  
1993 ◽  
Vol 86 (10) ◽  
pp. 649-656 ◽  
Author(s):  
D.J. Mutimer ◽  
P. Burra ◽  
J.M. Neuberger ◽  
S. Hubscher ◽  
J.A.C. Buckels ◽  
...  

2021 ◽  
Vol 2021 ◽  
pp. 1-4
Author(s):  
Patrick Lee ◽  
Brandon K. K. Fields ◽  
Tom Liang ◽  
Michael P. Dubé ◽  
Seth Politano

Veillonella species are commensal bacteria of the human oral, gut, and vaginal microbiota that are rarely identified as clinically relevant pathogens. Here, we describe a novel case of Veillonella atypica bacteremia in a patient with biopsy-proven alcoholic hepatitis. Veillonella species have been correlated with disease severity and hepatic encephalopathy in liver diseases such as autoimmune hepatitis and cirrhosis. Their abundance has also been recently observed to be increased in alcoholic hepatitis, where postinflammatory infections are known to impact mortality. This case report highlights the possible clinical manifestations that result from significant gut dysbiosis in patients with severe alcoholic hepatitis. Early identification and treatment of Veillonella bacteremia in susceptible populations could be crucial to survival given this organism’s predilection for causing life-threatening infections, including meningitis, endocarditis, and osteomyelitis.


2020 ◽  
Vol 04 (01) ◽  
pp. 036-039
Author(s):  
Alejandro Cracco ◽  
Lisandro Montorfano ◽  
Jason M. Vanatta

AbstractAlcohol-related liver disease (ALD) is one of the most common indications for liver transplantation. However, liver transplantation for alcoholic hepatitis (AH) remains controversial. The morbidity of severe alcoholic hepatitis (SAH) is extremely high, with most of the deaths occurring within the first 2 months. Multiple studies have recently demonstrated significant improvement in overall survival following liver transplantation in patients with SAH who failed medical management, with comparable rates to those transplanted electively. Concerns remain due to the small pool of donors and the high risk of alcohol relapse in this population. The traditional requirement of 6 months of abstinence prior to transplantation, or also known as “6-month rule” is controversial and has been criticized as whether it is a good predictor of long-term sobriety. Previous studies among patients with alcoholic cirrhosis have indicated that this rule poorly identifies patients who will relapse after liver transplantation. More recent studies in patients transplanted for SAH, have reported relapse rates that are comparable to those with abstinence periods >6 months. Applying stringent selection criteria appears to be key in identifying patients who are less likely to relapse after transplantation, and therefore prolonging patient and graft life. However, further research is needed to identify patients at risk and create appropriate screening tools. In this article, we present a review of currently available data on this topic.


2003 ◽  
Vol 36 (4) ◽  
pp. 285-288
Author(s):  
Tomoya Hirano ◽  
Katsunobu Yoshioka ◽  
Kae Teramoto ◽  
Takashi Morikawa ◽  
Noriyuki Okada ◽  
...  

2016 ◽  
Vol 64 (2) ◽  
pp. S241-S242
Author(s):  
S.K. Sharma ◽  
J.S. Maras ◽  
S. Hussain ◽  
S. Das ◽  
V. Khillan ◽  
...  

1994 ◽  
Vol 20 (2) ◽  
pp. 306-307 ◽  
Author(s):  
Thông Dao ◽  
Isabelle Lecointe ◽  
Marie-Astrid Piquet ◽  
Isabelle Jardin-Grimaux ◽  
Nicole Bouvard ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document